BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 482100)

  • 1. [Haemorrhagic complications using streptokinase during 98 treatments. Place of the biological surveillance (author's transl)].
    Conard J; Samama M; Milochevitch R; Horellou MH; Chabrun B; Prestat J
    Nouv Presse Med; 1979 Apr; 8(16):1319-25. PubMed ID: 482100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Side effects of thrombolytic treatment with porcine plasmin and low dose streptokinase.
    Marbet GA; Eichlisberger R; Duckert F; Ritz R; da Silva MA; Biland L; Widmer LK; Schmitt HE
    Thromb Haemost; 1982 Oct; 48(2):196-200. PubMed ID: 6217582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical changes noted during intermittent administration of streptokinase.
    Verstraete M; Vermylen J; Schetz J
    Thromb Haemost; 1978 Feb; 39(1):61-8. PubMed ID: 148118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The significance of changes in fibrinogen levels during thrombolytic therapy in myocardial infarct].
    Malý J; Pecka M; Pidrman V; Hamet A; Gregor J; Vodicka L; Siroký O; Tichý M
    Vnitr Lek; 1991 Mar; 37(3):229-37. PubMed ID: 2031311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of the use of the thromboxane A2 antagonist, sulotroban, in combination with streptokinase for local thrombolysis in patients with recent peripheral arterial occlusions: clinical effects, platelet function and fibrinolytic parameters.
    Lonsdale RJ; Heptinstall S; Westby JC; Berridge DC; Wenham PW; Hopkinson BR; Makin GS
    Thromb Haemost; 1993 Feb; 69(2):103-11, 123. PubMed ID: 8456421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Local thrombolysis in peripheral arterial occlusion].
    Hess H
    Herz; 1989 Feb; 14(1):12-21. PubMed ID: 2522076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombolytic treatment of arteriopathies].
    Fiessinger JN; Aiach M; Vayssairat M; Juillet Y; Cormier JM; Housset E
    Ann Anesthesiol Fr; 1978; 19(8):739-45. PubMed ID: 31119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemorrhage vs rethrombosis after thrombolysis for acute myocardial infarction.
    Timmis GC; Mammen EF; Ramos RG; Gordon S; Gangadharan V; Hauser AM; Westveer DC; Stewart JR
    Arch Intern Med; 1986 Apr; 146(4):667-72. PubMed ID: 3963947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of iliac artery stenosis with low dose streptokinase (author's transl)].
    Bopp J; Martin M; Büchner U; Auel H
    Dtsch Med Wochenschr; 1977 Feb; 102(6):198-201. PubMed ID: 137806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fibrinolysis and hemorrhage after streptokinase in acute myocardial infarct].
    Cassin M; Charmet PA; Rellini G; Molaro G; Bitto S; Brieda M; Zanuttini D
    G Ital Cardiol; 1987 Jul; 17(7):601-4. PubMed ID: 3678711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LYS-plasminogen shortens the duration of local thrombolytic treatment of peripheral arterial occlusions--a randomized controlled trial.
    Poredos P; Videcnik V
    Wien Klin Wochenschr; 1999 Jan; 111(1):21-5. PubMed ID: 10067266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of iliac artery stenoses with low doses of streptokinase].
    Martin M; Auel H; Bopp J; Büchner U
    Dtsch Med Wochenschr; 1977 May; 102(20):772-3. PubMed ID: 862526
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hemorrhagic risk in intravenously administered thrombolytic treatment in acute myocardial infarction].
    Acar J; Dorent R; Vahanian A; Michel PL; Cormier B; Slama M; Cazaux P; Conard J; Verdy E; Samama M
    Arch Mal Coeur Vaiss; 1988 May; 81 Spec No():59-65. PubMed ID: 3142430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-arterial thrombolytic therapy in peripheral vascular disease.
    Comerota AJ; Rubin RN; Tyson RR; White JV; Williams FF; Soulen RL; Sherry S
    Surg Gynecol Obstet; 1987 Jul; 165(1):1-8. PubMed ID: 3589918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systemic thrombolysis of arterial occlusions of the lower extremities. Comparison of various treatment schedules].
    Lämmle B; Noll G; Christe M; Fritschi J; Czendlik C; Marbet GA; Biland L; Da Silva A; Huber P; Widmer LK
    Schweiz Med Wochenschr; 1983 Oct; 113(43):1570-6. PubMed ID: 6227992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acylated streptokinase--plasminogen complex in patients with acute myocardial infarction.
    Walker ID; Davidson JF; Rae AP; Hutton I; Lawrie TD
    Thromb Haemost; 1984 Apr; 51(2):204-6. PubMed ID: 6377564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The systemic fibrinolytic effect of BRL 26921 during the treatment of acute peripheral arterial occlusions.
    Earnshaw JJ; Westby JC; Makin GS; Hopkinson BR
    Thromb Haemost; 1986 Apr; 55(2):259-62. PubMed ID: 3520938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-arterial segmental thrombolysis in patients with arterial embolism of cardiac origin.
    Benedek I; Hintea T; Benedek I
    Rom J Intern Med; 1999; 37(1):15-23. PubMed ID: 15523941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Actilyse: biological aspects].
    Samama M; Cormier B; Conard J
    Arch Mal Coeur Vaiss; 1988 May; 81 Spec No():51-7. PubMed ID: 3142427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is haemorrhagic myocardial infarction more common with streptokinase?
    Naik AM; Nabar AA; Lokhandwala YY; Kulkarni HL; Deshpande JR; Sivaraman A
    Indian Heart J; 1997; 49(4):387-90. PubMed ID: 9358661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.